Increased expression of the Nogo receptor in the hippocampus and its relation to the neuropathology in Alzheimer's disease

Human Pathology

Volumn 38, Issue 3, 2007, Pages 426-434

  Zhu, Hong Yan ^a,b   Guo, Hou Fu ^a,b   Hou, Hai Long ^a,b   Liu, Ya Jing ^a,b   Sheng, Shu Li ^c   Zhou, Jiang Ning ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Hippocampus; Hyperphosphorylated tau; Nogo 66 receptor; Senile plaque

Indexed keywords

NOGO 66 RECEPTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; AXONAL INJURY; BRAIN REGION; CELL COUNT; CELL LABELING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE FIBER REGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PYRAMIDAL NERVE CELL; SENILE PLAQUE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIBODIES, MONOCLONAL; FEMALE; FLUOROIMMUNOASSAY; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MYELIN PROTEINS; RECEPTORS, CELL SURFACE;

EID: 33846855551     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.09.010     Document Type: Article

References (34)

1. Blessed G., Tomlinson B.E., and Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114 (1968) 797-811
2. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch Neurol 42 (1985) 1097-1111
3. Fournier A.E., GrandPre T., and Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409 (2001) 341-346
4. Woolf C.J., and Bloechlinger S. Neuroscience: it takes more than two to Nogo. Science 297 (2002) 1132-1134
5. Josephson A., Trifunovski A., Scheele C., et al. Activity-induced and developmental downregulation of the Nogo receptor. Cell Tissue Res 311 (2003) 333-342
6. Meier S., Brauer A.U., Heimrich B., et al. Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure. FASEB J 17 (2003) 1153-1155
7. Bandtlow C.E., Dlaska M., Pirker S., et al. Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy. Eur J Neurosci 20 (2004) 195-206
8. Satoh J., Onoue H., Arima K., et al. Nogo-A and Nogo receptor expression in demyelinating lesions of multiple sclerosis. J Neuropathol Exp Neurol 64 (2005) 129-138
9. Park J.H., Gimbel D.A., GrandPre T., et al. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci 26 (2006) 1386-1395
10. Fournier A.E., Gould G.C., Liu B.P., et al. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J Neurosci 22 (2002) 8876-8883
11. Wang K.C., Kim J.A., Sivasankaran R., et al. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420 (2002) 74-78
12. Wong S.T., Henley J.R., Kanning K.C., et al. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 5 (2002) 1302-1308
13. Mi S., Lee X., Shao Z., et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7 (2004) 221-228
14. Counts S.E., Nadeem M., Wuu J., et al. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol 56 (2004) 520-531
15. Mufson E.J., Ma S.Y., Dills J., et al. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 443 (2002) 136-153
16. Yaar M., Zhai S., Pilch P.F., et al. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J Clin Invest 100 (1997) 2333-2340
17. Hu X.Y., Zhang H.Y., Qin S., et al. Increased p75 (NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol 178 (2002) 104-111
18. Josephson A., Trifunovski A., Widmer H.R., et al. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 453 (2002) 292-304
19. Wang X., Chun S.J., Treloar H., et al. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 22 (2002) 5505-5515
20. Wang Y.J., Chen G.H., Hu X.Y., et al. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Brain Res 1031 (2005) 101-108
21. Lu Y.P., Zeng M., Hu X.Y., et al. Estrogen receptor alpha-immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease. Exp Neurol 183 (2003) 482-488
22. Liu R.Y., Zhou J.N., Hoogendijk W.J., et al. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol 59 (2000) 314-322
23. Duvernoy H.M. The human hippocampus, functional anatomy, vascularization and serial sections with MRI (1997), Springer, Berlin
24. Domeniconi M., Cao Z., Spencer T., et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35 (2002) 283-290
25. Liu B.P., Fournier A., GrandPre T., et al. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297 (2002) 1190-1193
26. Wang K.C., Koprivica V., Kim J.A., et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417 (2002) 941-944
27. De Keyser F., Demol H., Raymaeckers J., et al. Peptides in immunology (1996), Wiley, Chichester 239-244
28. Mercken M., Vandermeeren M., Lubke U., et al. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol (Berl) 84 (1992) 265-272
29. Braak E., Braak H., and Mandelkow E.M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (Berl) 87 (1994) 554-567
30. Buchanan S.G., and Gay N.J. Structural and functional diversity in the leucine-rich repeat family of proteins. Prog Biophys Mol Biol 65 (1996) 1-44
31. He X.L., Bazan J.F., McDermott G., et al. Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron 38 (2003) 177-185
32. Barton W.A., Liu B.P., Tzvetkova D., et al. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J 22 (2003) 3291-3302
33. Taketomi M., Kinoshita N., Kimura K., et al. Nogo-A expression in mature oligodendrocytes of rat spinal cord in association with specific molecules. Neurosci Lett 33 (2002) 37-40
34. Golde T.E., Eckman C.B., Younkin S.G., et al. Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim Biophys Acta 1502 (2000) 172-187